Search Results
Genes May Predict Trastuzumab Outcomes in Breast Cancer
Identifying Genes That Can Predict if Breast Cancer Drug Is Working - Mayo Clinic
Immune Function Marker Does Not Predict Benefit of Trastuzumab in HER+ Breast Cancer Patients
Independent validation of the HER2DX genomic test in HER2-positive breast cancer
Charles M. Perou, PhD, Discusses Predicting Outcomes in Breast Cancer
Role of HER2 expression and pCR in predicting early outcomes in HER2-positive breast cancer
Targeting Breast Cancer Stem Cells
Breast Cancer Diagnosis and Treatment - Stanley Lipkowitz
Dr. Aju Mathew, Assistant Professor of Medicine talking on Breast Cancer at our Foster City Lab
Kathy S. Albain: Patients with luminal A and B / HER2 negative breast cancer
Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott Christensen
Dr. Mark Pegram on Combining Trastuzumab and Pertuzumab
